Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Revenue: 2021-2024

Historic Revenue for Amylyx Pharmaceuticals (AMLX) over the last 4 years, with Dec 2024 value amounting to $114.3 million.

  • Amylyx Pharmaceuticals' Revenue fell 79.28% to $26.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $116.3 million, marking a year-over-year decrease of 73.04%. This contributed to the annual value of $114.3 million for FY2024, which is 73.52% down from last year.
  • As of FY2024, Amylyx Pharmaceuticals' Revenue stood at $114.3 million, which was down 73.52% from $431.4 million recorded in FY2023.
  • In the past 5 years, Amylyx Pharmaceuticals' Revenue ranged from a high of $431.4 million in FY2023 and a low of $285,000 during FY2021.
  • In the last 3 years, Amylyx Pharmaceuticals' Revenue had a median value of $114.3 million in 2024 and averaged $190.9 million.
  • Per our database at Business Quant, Amylyx Pharmaceuticals' Revenue surged by 9,410.18% in 2022 and then plummeted by 73.52% in 2024.
  • Amylyx Pharmaceuticals' Revenue (Yearly) stood at $285,000 in 2021, then soared by 9,410.18% to $27.1 million in 2022, then soared by 1,491.77% to $431.4 million in 2023, then slumped by 73.52% to $114.3 million in 2024.